Q2 2018 Holdings
Filed 2018-08-14 | 119 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $1.8B | 11,959,824 | 53.7% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $714.3M | 7,583,084 | 20.9% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $415.8M | 27,228,338 | 12.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $188.7M | 2,837,352 | 5.5% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $80.3M | 14,012,172 | 2.3% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $79.7M | 961,754 | 2.3% |
| Cerus Corporation(CERS) | COM | 157085101 | $71.7M | 10,749,937 | 2.1% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $11.3M | 3,621,962 | 0.3% |
| Autolus Therapeutics plc(AUTL) | SPON ADS | 05280R100 | $6.3M | 235,294 | 0.2% |
| Seattle Genetics, Inc. | COM | 812578102 | $3.4M | 51,046,060 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.3M | 34,251,034 | 0.1% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $1.5M | 121,534 | 0.0% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.4M | 50,000 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $1.3M | 180,582 | 0.0% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $1.2M | 100,000 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.1M | 8,555,894 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $695.0K | 13,790,574 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $327.0K | 1,169,278 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $195.2K | 5,025,298 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $123.9K | 2,513,462 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $114.6K | 1,384,130 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $106.3K | 5,509,560 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $96.0K | 613,300 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $94.9K | 5,656,196 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $92.8K | 944,624 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $84.7K | 2,708,200 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | $70.0K | 22,669,509 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $66.0K | 4,917,700 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $61.7K | 8,399,411 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $52.1K | 3,000,000 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K405 | $51.0K | 38,654,811 | 0.0% |
| Tricida, Inc.(1T7) | COM | 89610F101 | $47.8K | 1,600,000 | 0.0% |
| GW Pharmaceuticals plc | ADS | 36197T103 | $44.9K | 321,800 | 0.0% |
| Novavax, Inc. | NOTE 3.75% 2/1/23 | 670002AB0 | $42.7K | $73,500,000 | 0.0% |
| Abeona Therapeutics Inc.(ABEO1EUR) | COM | 00289Y107 | $35.0K | 2,184,364 | 0.0% |
| Erytech Pharma S.A. | SPONSORED ADR | 29604W108 | $34.5K | 3,085,969 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $32.3K | 872,072 | 0.0% |
| Endocyte, Inc. | COM | 29269A102 | $31.4K | 2,277,799 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $31.4K | 200,000 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $30.2K | 4,093,447 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $29.0K | 10,934,154 | 0.0% |
| Merus N.V. | COM | N5749R100 | $26.4K | 1,160,014 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $24.0K | 259,894 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $22.9K | 605,000 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $21.7K | 1,283,929 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $21.5K | 433,121 | 0.0% |
| Solid Biosciences Inc. | COM | 83422E105 | $20.9K | 587,884 | 0.0% |
| Zymeworks Inc. | COM | 98985W102 | $19.4K | 1,311,085 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $18.2K | 1,283,923 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $18.1K | 673,908 | 0.0% |